Corticosteroids in immunocompromised ICU patients with severe COVID-19: a multicenter retrospective study

Corticosteroids in immunocompromised ICU patients with severe COVID-19: a multicenter retrospective study

Abstract Immunocompromised patients were excluded most of the time from trials testing corticosteroids in COVID-19. This study aimed to assess the associations between early corticosteroid use and (1) mortality at day 60, and (2) the occurrence of nosocomial infections in immunocompromised patients...

Full description

Saved in:
Bibliographic Details
Main Authors: Claire Dupuis, Jean-François Timsit, Julien Domitile, Kada Klouche, Laure Calvet, Mathilde Neuville, Shidasp Siami, Yves Cohen, Virginie Laurent, Bruno Mourvillier, Dany Goldgran-Toledano, Carole Schwebel, Stéphane Ruckly, Ferhat Meziani, Matthieu Raymond, Armand Mekontso Dessap, Bertrand Souweine
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Immunosuppression
ICU
COVID-19
Steroids
Outcomes
Nosocomial infections
Online Access:https://doi.org/10.1038/s41598-025-10864-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-10864-8

Similar Items